Balyasny Asset Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Balyasny Asset Management's RGEN Position: Q1 2026 in Review
Balyasny Asset Management increased its Repligen (RGEN) stake by 9.1% in Q1 2026, buying an estimated $1.46M and bringing the position to 125,469 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #828.
Balyasny Asset Management first reported a position in RGEN in Q2 2018 and has held it in 20 quarters since. The position peaked at $103M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Balyasny Asset Management held 125,469 shares of Repligen worth $14.8M as of Q1 2026.
- Balyasny Asset Management bought 10,416 Repligen shares in Q1 2026, an estimated $1.46M.
- Repligen made up 0.02% of Balyasny Asset Management's portfolio in Q1 2026, its #828 holding.
- Balyasny Asset Management first reported a position in Repligen in Q2 2018 and has held it in 20 quarters since.
- Balyasny Asset Management's Repligen position peaked at $103M in Q3 2025.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.